NCT05694338 Frailty in Patients With Gastrointestinal Cancer Who Are Undergoing Major Surgery Status RECRUITING Phase N/A
NCT05664178 Remote Resistance Exercise Powering Survivors - Gastrointestinal Oncology Status RECRUITING Phase PHASE1/PHASE2
NCT05651672 Pemigatinib in the Advanced Gastrointestinal Cancer With FGFR 1-3 Alterations Status RECRUITING Phase PHASE2
NCT05648084 Artificial Intelligence and Cancer Staging in Upper Gastrointestinal Malignancies Status COMPLETED Phase N/A
NCT05629065 Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC) Status ACTIVE_NOT_RECRUITING Phase NA
NCT05606848 To Test the Food for Special Medical Purpose in Perioperative Patients With Gastrointestinal Cancer Status RECRUITING Phase NA
NCT05600933 Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment Status ENROLLING_BY_INVITATION Phase N/A
NCT05587972 Real World Treatment Experience of Patients With Breast, Lung, or GI Cancer or Multiple Myeloma Using Remote Symptom Monitoring Status ACTIVE_NOT_RECRUITING Phase NA
NCT05559775 A Single-Arm Phase II Exploratory Clinical Study of Pemigatinib in the Treatment of Advanced Gastrointestinal Cancer (Excluding Biliary Tract Cancer) Patients With FGFR Alterations Who Have Failed Standard Therapy Status UNKNOWN Phase PHASE2
NCT05494320 the Effect of ABCC2 Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving Oxaliplatin Status UNKNOWN Phase N/A
NCT05462314 Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies Status COMPLETED Phase N/A
NCT05429866 Immunological Variables Associated to ICI Toxicity in Cancer Patients Status UNKNOWN Phase PHASE2
NCT05420558 Fibroblast Activation Protein Inhibitor PET/CT Imaging in Malignant Tumor of Digestive System Status UNKNOWN Phase N/A
NCT05411133 Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients Status COMPLETED Phase PHASE1
NCT05381038 Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AI Status RECRUITING Phase PHASE1/PHASE2
NCT05375643 SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention) Status RECRUITING Phase NA